Autobacs Seven Co (9832) AI Stock Analysis

• Market Cap: ¥113.78B
• Dividend Yield: 4.11%
• Average Volume (3M): 121.95K
• Price to Earnings (P/E): 14.1
• Beta (1Y): 0.40
• Revenue Growth: 8.56%
• EPS Growth: 27.21%
• Country: JP
• Employees: 4,385
• Sector: Services
• Sector Strength: N/A
• Industry: Specialty Retail
• EPS (TTM): 6.21
• Shares Outstanding: 82,050,100
• 10 Day Avg. Volume: 115,720
• 30 Day Avg. Volume: 121,946
• PEG Ratio: 0.34
• Price to Book (P/B): 0.88
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,604.07
• Price Target Upside: 9.57% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 66 Neutral
• Price Target: ¥1,563.00 ▲(6.76%Upside)

The overall score reflects strong financial performance in terms of revenue and profit growth, tempered by concerns regarding declining cash flow. Valuation is reasonable, with a supportive dividend yield. Technical analysis suggests neutral momentum, with no clear directional trend.

Autobacs Seven Co Business Overview & Revenue Model

Company Description

Autobacs Seven Co., Ltd. is a Japanese company specializing in the automotive aftermarket sector. Founded in 1947, it operates a network of retail stores offering a wide range of automotive parts, accessories, and services. The company is known for its Autobacs stores, which provide car maintenance and repair services, as well as sales of tires, car electronics, and other automobile-related products. Autobacs Seven Co. is headquartered in Tokyo, Japan, and has expanded its operations internationally, including in Asia and Europe.

How the Company Makes Money

Autobacs Seven Co. generates revenue primarily through its retail operations, selling automotive parts and accessories directly to consumers via its network of Autobacs stores. Additional revenue streams include providing car maintenance and repair services, which attract a steady customer base seeking routine vehicle upkeep and emergency repairs. The company also benefits from its private label products, which offer higher margins compared to third-party brands. Furthermore, Autobacs Seven Co. has established franchise agreements, allowing it to earn franchise fees and royalties from partner-operated stores. The company's international expansion contributes to its revenue by tapping into new markets. Key partnerships with automotive manufacturers and suppliers help secure a diverse product lineup, enhancing customer retention and attracting new clientele.

Autobacs Seven Co Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	238.44B	229.86B	236.24B	228.59B	220.45B	221.40B
Gross Profit	81.34B	75.42B	79.46B	77.15B	73.29B	70.75B
EBITDA	10.93B	15.66B	16.41B	16.11B	14.73B	12.25B
Net Income	4.89B	6.36B	7.24B	7.01B	7.05B	3.76B
Balance Sheet
Total Assets	246.07B	194.95B	194.33B	189.91B	187.91B	172.80B
Cash, Cash Equivalents and Short-Term Investments	33.39B	31.30B	28.21B	29.07B	43.85B	33.83B
Total Debt	23.42B	9.32B	12.19B	10.76B	12.66B	7.30B
Total Liabilities	114.06B	65.80B	67.37B	67.02B	64.08B	52.83B
Stockholders Equity	131.85B	128.84B	126.62B	122.55B	123.18B	119.25B
Cash Flow
Free Cash Flow	0.00	5.28B	3.50B	-588.00M	13.17B	7.17B
Operating Cash Flow	0.00	14.43B	10.69B	5.71B	17.16B	10.60B
Investing Cash Flow	0.00	-449.00M	-7.65B	-7.71B	-6.08B	-3.37B
Financing Cash Flow	0.00	-7.41B	-3.50B	-12.30B	-309.00M	-9.68B

Autobacs Seven Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1464.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9832, the sentiment is Positive. The current price of 1464 is above the 20-day moving average (MA) of 1444.10, above the 50-day MA of 1451.86, and above the 200-day MA of 1438.59, indicating a bullish trend. The MACD of 1.33 indicates Negative momentum. The RSI at 59.55 is Neutral, neither overbought nor oversold. The STOCH value of 79.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9832.

Autobacs Seven Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2751	74 Outperform	¥39.41B	19.30		0.27%	24.11%	22.03%
2666	71 Outperform	¥2.17B	8.07		2.00%	5.32%	2.13%
2674	68 Neutral	¥23.68B	10.24		4.45%	11.38%	10.55%
2730	68 Neutral	¥215.27B	15.37		2.32%	6.52%	47.34%
9832	66 Neutral	¥113.78B	14.05	6.22%	4.11%	8.56%	27.21%
2681	64 Neutral	¥64.80B	14.28		2.08%	-1.42%	-58.51%
Sector *	56 Neutral	HK$2.84B	5.37	-9.32%	8.02%	12.55%	-102.16%

Autobacs Seven Co Corporate Events

Autobacs Seven Co. Announces Disposal of Treasury Shares for Director Remuneration

Autobacs Seven Co., Ltd. announced the disposal of 42,500 treasury shares as part of its Restricted Stock Remuneration Plan, aimed at enhancing value sharing with shareholders. This move is intended to motivate directors by aligning their interests with the company’s long-term value, as shares will be held until retirement, fostering sustained corporate value enhancement.

Autobacs Seven Co. Reports Strong Financial Performance for FY2025

Autobacs Seven Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with net sales increasing by 8.6% and operating profit rising by 51.4% compared to the previous year. The company’s strategic initiatives have resulted in a robust financial position, with a notable increase in profit attributable to owners of the parent by 28%. This financial growth reflects positively on Autobacs’ market positioning and indicates a strong outlook for stakeholders.

Autobacs Seven Co. Reports Strong Financial Growth in FY2025

Autobacs Seven Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ended March 31, 2025, with an 8.6% increase in net sales and a 51.4% rise in operating profit compared to the previous year. The company has also forecasted continued growth for the next fiscal year, indicating a strong market position and potential positive impact for stakeholders.